National and Kapodistrian University of Athens
Μελέτη του ρόλου των φυλετικών ορμονών στην παθογένεια του συνδρόμου Sjogren: ανάλυση της έκφρασης οιστρογονικών υποδοχέων και της αποκρισιμότητας στα οιστρογόνα των επιθηλιακών κυττάρων των σιελογόνων αδένων
Abstract
dc:descriptionSjögren syndrome (SS) or autoimmune epithelitis is a chronic autoimmune disorder ofthe exocrine glands, mainly of the salivary and the lacrimal glands, that affects about1-3% of the general population and is characterized by strong female preponderance.Experimental evidence suggests that salivary gland epithelial cells (SGEC) are centralto the autoimmune lesion in SS, not only as target cells, but also as an activeparticipant in the induction and perpetuation of the autoimmune response. SGECappear to actively participate in immune responses and to possess immune function,whereas the perturbation of this function possibly contributes to the development ofthe autoimmune response in the context of the chronic activation of the epithelium.The strong female preponderance of the disease (women/men 9:1), as well as theusual occurrence of the disease around menopause led to the classic hypothesis thatestrogens are central to the pathophysiology of the disease, whereas experimentalanimal models have indicated the contribution of estrogens in disease pathogenesis.Experimental and epidemiological data indicate the paramount importance of bothSGEC and estrogens in SS pathogenesis, as well as that the salivary gland is normalysubjected to estrogenic influence. However, the expression and functional capacity ofestrogen receptor alpha and estrogen receptor beta (ERα and ERβ) in normal humansalivary epithelium as well as the estrogenic responsiveness and the expression ofERα and ERβ in the salivary epithelium of SS patients has not been assessed.In the present study, the expression and functional capacity of ERα and ERβ,the immunomodulatory potential of estrogens and the estrogenic effect in theproliferation and the induction of apoptosis in SGEC was initially assessed in normalsalivary epithelium. After the detection of the expression and of the functionalcapacity of ERα and ERβ proteins in normal salivary epithelium, the estrogenic responsiveness and the expression of ERα and ERβ proteins was comparativelyassessed in the salivary epithelium of SS patients and of healthy controls. Theexpression of ERα and ERβ proteins and their isoforms (ERαΔ3-isoform, ERβ1-long[currently regarded as the wild-type ERβ protein] and ERβ1-short forms and ERβ2-isoform) was analysed in tissue specimens (immunohistochemical experiments), aswell as in cultured non-neoplastic SGEC lines (immunohistochemical andimmunoblotting experiments), derived from minor salivary gland biopsies, frompatients that had undergone biopsy during their diagnostic evaluation for possible SS.Immunohistochemical experiments revealed strong expression of ERα, ERβ1 andERβ2 proteins, with similar staining pattern and intensity in both the nucleus andcytoplasm of SGEC. The epithelial expression of estrogen receptors was confirmedby immunoblotting experiments in cellular extracts from SGEC, where the full-lengthERα and the ERα-Δ3 isoform, ERβ1-long, ERβ1-short and ERβ2-long proteins weredetected. The application of a standard estrogenic inhibition assay of cytokine inducedadhesion molecules expression revealed that normal SGEC are responsive toestrogens, as well as the functional capacity of ERα and ERβ. The modulation ofconstitutive and IFNγ-induced CD54/ICAM.1 molecules expression by treatment withestrogenic agonists was analyzed by flow cytometry. In this assay the pretreatment ofcultured SGEC with 17β-estradiol [Ε2] and the selective ERα- and ERβ- agonistspropylpyrazole-triol [PPT] and diarylpropiolnitrile [DPN] respectively, inhibited theIFNγ-induced surface expression of intercellular adhesion molecule-1(CD54/ICAM.1). The above described findings have indicated the constitutiveexpression of functional ERα and ERβ proteins by normal salivary epithelium, thatapparently mediate immunomodulatory effects. E2 as well as selective ERα- and ERβ- agonists were not found to modulate constitutive ICAM.1 expression, theproliferation rate or the apoptosis in normal cultured SGEC.The estrogenic responsiveness of the SGEC of SS-patients was then evaluated.For this purpose, cultured SGEC-lines derived from SS-patients and from controlindividuals were comparatively evaluated in the standard estrogenic inhibition assaythat was described above. Constitutive ICAM.1 expression was not modulated byestradiol treatment in either the control- or the SS-SGEC lines. In line with our initialresults, in control SGEC E2-pretreatment resulted in siginificant inhibition of theIFNγ-induced ICAM.1 expression. However, such inhibitory effect was not observedin the SS-SGEC lines. This defective estrogenic responsiveness did not appear tocorrelate with the expression of ERα and ERβ proteins and their isoforms, as nodifferences in the pattern or intensity of ERα and ERβ proteins were observedbetween the salivary epithelial cells of SS-patients and those of control individuals.In conclusion, the present study has indicated the expression of functionalERα and ERβ proteins in normal salivary epithelium. Estrogens appear to modulatethe epithelial responses to inflammatory stimuli as suggested by the inhibition ofIFNγ-induced ICAM.1 expression by 17β-estradiol and selective ERα- and ERβ-agonists. Estrogen responsiveness of cultured SGEC derived from patients with SSwas found significantly reduced, a finding that did not appear to correlate with theexpression pattern of ERα and ERβ proteins.On the basis of the immunoregulatoryproperties of estrogens, the reduced responsiveness of of SGEC of SS patients to 17β-estradiol, may be also of direct pathophysiological relevance, possibly reflecting theperturbed immunological function of SGEC in SS, and may well be a functionalmanifestation of constitutively active cellular mechanisms that apparently operate inthe epithelia of SS patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsinti, Maria
- Τσιντή, Μαρία
Subjects
dc:subject × 19- Σύνδρομο Sjogren
- Οιστρογονικοί υποδοχείς
- Επιθηλιακά κύτταρα
- Σιελογόνοι αδένες
- Οιστρογονική αποκρισιμότητα
- Ανοσορρυθμιστική επίδραση
- Ιντερφερόνη-γ
- Διακυτταρικό μόριο προσκόλλησης-1
- Sjogren syndorme
- Estrogen receptors
- Epithelial cells
- Salivary glands
- Estrogenic responsiveness
- Imunoregulatory role
- Intercellular adhesion molecule-1
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/31783